Comparing the Effectiveness of Bevacizumab to Ranibizumab in Patients with Exudative Age-Related Macular Degeneration. The BRAMD Study.

Comparing the Effectiveness of Bevacizumab to Ranibizumab in Patients with Exudative Age-Related Macular Degeneration. The BRAMD Study.

To compare the effectiveness of bevacizumab and ranibizumab in the treatment of exudative age-related macular degeneration (AMD).Multicentre, randomized, controlled, double-masked clinical trial in 327 patients. The non-inferiority margin was 4 letters.Patients ≥ 60 years of age with primary or recu...

Full description

Bibliographic Details
Main Authors: A M E Schauwvlieghe, G Dijkman, J M Hooymans, F D Verbraak, C B Hoyng, M G W Dijkgraaf, T Peto, J R Vingerling, R O Schlingemann
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4874598?pdf=render

Internet

http://europepmc.org/articles/PMC4874598?pdf=render

Similar Items